Goldman Sachs Group Inc. boosted its holdings in shares of Afya Limited (NASDAQ:AFYA - Free Report) by 167.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 45,093 shares of the company's stock after purchasing an additional 28,226 shares during the quarter. Goldman Sachs Group Inc.'s holdings in Afya were worth $809,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in the business. Doma Perpetual Capital Management LLC raised its holdings in Afya by 4.4% in the 1st quarter. Doma Perpetual Capital Management LLC now owns 592,220 shares of the company's stock valued at $10,619,000 after acquiring an additional 25,111 shares in the last quarter. Wealthedge Investment Advisors LLC acquired a new position in Afya in the 1st quarter valued at approximately $230,000. Nuveen LLC acquired a new position in Afya in the 1st quarter valued at approximately $226,000. Cerity Partners LLC acquired a new position in Afya in the 1st quarter valued at approximately $476,000. Finally, Yorktown Management & Research Co Inc acquired a new position in Afya in the 1st quarter valued at approximately $321,000. Institutional investors own 88.02% of the company's stock.
Analyst Ratings Changes
A number of brokerages have recently issued reports on AFYA. Zacks Research raised Afya to a "hold" rating in a report on Friday, August 8th. Citigroup raised Afya from a "sell" rating to a "neutral" rating and dropped their price target for the company from $16.00 to $14.00 in a report on Tuesday, July 29th. JPMorgan Chase & Co. raised Afya from a "neutral" rating to an "overweight" rating and raised their price target for the company from $23.50 to $24.50 in a report on Monday, September 8th. Wall Street Zen raised Afya from a "buy" rating to a "strong-buy" rating in a report on Saturday, September 13th. Finally, UBS Group raised Afya from a "neutral" rating to a "buy" rating and dropped their price target for the company from $19.50 to $19.00 in a report on Monday, September 8th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $18.20.
Get Our Latest Research Report on Afya
Afya Stock Up 0.7%
Shares of AFYA opened at $16.17 on Wednesday. The company has a market capitalization of $1.52 billion, a PE ratio of 12.25, a PEG ratio of 0.48 and a beta of 0.56. Afya Limited has a 12 month low of $13.47 and a 12 month high of $19.90. The stock's 50-day moving average price is $15.04 and its two-hundred day moving average price is $16.94. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.22.
Afya Profile
(
Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Articles
Want to see what other hedge funds are holding AFYA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Afya Limited (NASDAQ:AFYA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.